Sven Francque fund. clinical researcher - full professor

Publications Sven Francque

Implementation of a liver health check in people with type 2 diabetes

Source
Lancet gastroenterology & hepatology - ISSN 2468-1253-9:1 (2024) p. 83-91
Author(s)
    Kushala W.M. Abeysekera, Luca Valenti, Zobair Younossi, John F. Dillon, Alina M. Allen, Mazen Noureddin, Mary E. Rinella, Frank Tacke, Sven Francque, Pere Gines, Maja Thiele, Philip N. Newsome, Indra Neil Guha, Mohammed Eslam, Joern M. Schattenberg, Saleh A. Alqahtani, Marco Arrese, Annalisa Berzigotti, Adriaan G. Holleboom, Cyrielle Caussy, Kenneth Cusi, Michael Roden, Hannes Hagstroem, Vincent Wai-Sun Wong, Vincent Mallet, Laurent Castera, Jeffrey V. Lazarus, Emmanuel A. Tsochatzis

Efficacy and safety of elafibranor in primary biliary cholangitis

Source
The New England journal of medicine - ISSN 0028-4793-390 (2024) p. 795-805
Author(s)
    Kris V. Kowdley, Christopher L. Bowlus, Cynthia Levy, Ulus S. Akarca, Mario Reis Alvares-da-Silva, Pietro Andreone, Marco Arrese, Christophe Corpechot, Sven Francque, Michael A. Heneghan, Pietro Invernizzi, David Jones, Frederik C. Kruger, Eric Lawitz, Marlyn J. Mayo, Mitchell L. Shiffman, Mark G. Swain, Jose Miguel Valera, Victor Vargas, John M. Vierling, Alejandra Villamil, Carol Addy, Julie Dietrich, Jean-Michel Germain, Sarah Mazain, Dragutin Rafailovic, Bachirou Tadde, Benjamin Miller, Jianfen Shu, Claudia O. Zein, Jorn M. Schattenberg

Learnings from the graveyard of phase 2 and 3 nonalcoholic steatohepatitis trials

Source
Clinical gastroenterology and hepatology - ISSN 1542-3565-22:1 (2024) p. 16-19
Author(s)

Phase 2, open-label, rollover study of cenicriviroc for liver fibrosis associated with metabolic dysfunction-associated steatohepatitis

Source
Hepatology Communications - ISSN 2471-254X-8:2 (2024) p. 1-8
Author(s)
    Sven Francque, Alexander Hodge, Jerome Boursier, Ziad H. Younes, Gerardo Rodriguez-Araujo, Grace S. Park, Naim Alkhouri, Manal F. Abdelmalek

Loss of PPARα function promotes epigenetic dysregulation of lipid homeostasis driving ferroptosis and pyroptosis lipotoxicity in metabolic dysfunction associated Steatotic liver disease (MASLD)

Source
Frontiers in molecular medicine - ISSN 2674-0095-3 (2024) p. 1-19
Author(s)